nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—Epirubicin—peripheral nervous system neoplasm	0.632	1	CbGbCtD
Suramin—SIRT5—ganglion—peripheral nervous system neoplasm	0.0169	0.125	CbGeAlD
Suramin—P2RX4—nerve—peripheral nervous system neoplasm	0.0161	0.12	CbGeAlD
Suramin—SIRT1—nerve—peripheral nervous system neoplasm	0.0141	0.105	CbGeAlD
Suramin—F2—forelimb—peripheral nervous system neoplasm	0.0137	0.101	CbGeAlD
Suramin—PLA2G2A—tongue—peripheral nervous system neoplasm	0.00967	0.0718	CbGeAlD
Suramin—P2RX4—trigeminal ganglion—peripheral nervous system neoplasm	0.00783	0.0581	CbGeAlD
Suramin—P2RX4—parotid gland—peripheral nervous system neoplasm	0.00738	0.0548	CbGeAlD
Suramin—SIRT1—trigeminal ganglion—peripheral nervous system neoplasm	0.00686	0.0509	CbGeAlD
Suramin—SIRT1—parotid gland—peripheral nervous system neoplasm	0.00647	0.048	CbGeAlD
Suramin—RYR1—trigeminal ganglion—peripheral nervous system neoplasm	0.00634	0.047	CbGeAlD
Suramin—FSHR—cerebellum—peripheral nervous system neoplasm	0.0055	0.0408	CbGeAlD
Suramin—PLA2G2A—trigeminal ganglion—peripheral nervous system neoplasm	0.0048	0.0357	CbGeAlD
Suramin—SIRT5—cerebellum—peripheral nervous system neoplasm	0.00361	0.0268	CbGeAlD
Suramin—P2RX4—cerebellum—peripheral nervous system neoplasm	0.00342	0.0254	CbGeAlD
Suramin—PLA2G4A—trigeminal ganglion—peripheral nervous system neoplasm	0.00334	0.0248	CbGeAlD
Suramin—SIRT1—cerebellum—peripheral nervous system neoplasm	0.00299	0.0222	CbGeAlD
Suramin—ARSA—cerebellum—peripheral nervous system neoplasm	0.00296	0.0219	CbGeAlD
Suramin—RYR1—cerebellum—peripheral nervous system neoplasm	0.00276	0.0205	CbGeAlD
Suramin—PLA2G4A—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.000772	0.00331	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00075	0.00321	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00074	0.00317	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000733	0.00314	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000715	0.00306	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000708	0.00303	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000707	0.00303	CbGpPWpGaD
Suramin—SIRT1—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.000679	0.00291	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000676	0.0029	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000676	0.00289	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000671	0.00287	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PTPN11—peripheral nervous system neoplasm	0.000653	0.0028	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000653	0.0028	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.000637	0.00273	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000629	0.00269	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000612	0.00262	CbGpPWpGaD
Suramin—ARSA—Metabolism—GNS—peripheral nervous system neoplasm	0.000588	0.00252	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000587	0.00251	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—AKT1—peripheral nervous system neoplasm	0.000585	0.00251	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000584	0.0025	CbGpPWpGaD
Suramin—PLA2G4A—p38 MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000584	0.0025	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000571	0.00245	CbGpPWpGaD
Suramin—ARSA—Metabolism—NME1—peripheral nervous system neoplasm	0.000564	0.00241	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000556	0.00238	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000555	0.00237	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000554	0.00237	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000552	0.00236	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000549	0.00235	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000548	0.00235	CbGpPWpGaD
Suramin—ARSA—Metabolism—COX2—peripheral nervous system neoplasm	0.000543	0.00232	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000538	0.00231	CbGpPWpGaD
Suramin—PLA2G4A—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.000537	0.0023	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000529	0.00227	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000524	0.00224	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000524	0.00224	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000516	0.00221	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000506	0.00217	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000497	0.00213	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.000494	0.00212	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000485	0.00208	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00048	0.00205	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000479	0.00205	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000474	0.00203	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000469	0.00201	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000462	0.00198	CbGpPWpGaD
Suramin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000459	0.00196	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000458	0.00196	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000451	0.00193	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.00044	0.00188	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000436	0.00187	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000435	0.00186	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000434	0.00186	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000433	0.00185	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.00043	0.00184	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000429	0.00184	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00042	0.0018	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00042	0.0018	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000418	0.00179	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000418	0.00179	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—AKT1—peripheral nervous system neoplasm	0.000417	0.00179	CbGpPWpGaD
Suramin—F2—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	0.000414	0.00177	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000411	0.00176	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—HRAS—peripheral nervous system neoplasm	0.000411	0.00176	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000404	0.00173	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000401	0.00172	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.0004	0.00171	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000386	0.00165	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000384	0.00164	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00038	0.00163	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GNS—peripheral nervous system neoplasm	0.000379	0.00162	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000376	0.00161	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000376	0.00161	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00037	0.00159	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000368	0.00158	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000367	0.00157	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000366	0.00157	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NME1—peripheral nervous system neoplasm	0.000363	0.00156	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000363	0.00155	CbGpPWpGaD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.00036	0.00154	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000356	0.00153	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000356	0.00153	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—COX2—peripheral nervous system neoplasm	0.00035	0.0015	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00035	0.0015	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000342	0.00146	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000325	0.00139	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00032	0.00137	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000318	0.00136	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000309	0.00132	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000304	0.0013	CbGpPWpGaD
Suramin—ARSA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000301	0.00129	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000301	0.00129	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.0003	0.00129	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000292	0.00125	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00029	0.00124	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	0.000287	0.00123	CbGpPWpGaD
Suramin—ARSA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000287	0.00123	CbGpPWpGaD
Suramin—ARSA—Metabolism—TH—peripheral nervous system neoplasm	0.000283	0.00121	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—HRAS—peripheral nervous system neoplasm	0.00028	0.0012	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000276	0.00118	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	0.000275	0.00118	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000265	0.00113	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000264	0.00113	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000261	0.00112	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000257	0.0011	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000255	0.00109	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	0.000254	0.00109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000253	0.00108	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000248	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—AKT1—peripheral nervous system neoplasm	0.000247	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000247	0.00106	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000245	0.00105	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000242	0.00104	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000242	0.00104	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000238	0.00102	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000236	0.00101	CbGpPWpGaD
Suramin—F2—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000233	0.001	CbGpPWpGaD
Suramin—ARSA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000231	0.00099	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000231	0.000988	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—peripheral nervous system neoplasm	0.00023	0.000983	CbGpPWpGaD
Suramin—ARSA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000227	0.000971	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000224	0.000961	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	0.000221	0.000948	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000217	0.000928	CbGpPWpGaD
Suramin—F2—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000216	0.000927	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000214	0.000914	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000213	0.000913	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000212	0.000906	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.00021	0.0009	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000209	0.000897	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000207	0.000887	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	0.000206	0.000883	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000205	0.000879	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000198	0.000847	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—BCHE—peripheral nervous system neoplasm	0.000194	0.000831	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000194	0.00083	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000193	0.000828	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000192	0.00082	CbGpPWpGaD
Suramin—F2—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000189	0.00081	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000188	0.000805	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000185	0.000793	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TH—peripheral nervous system neoplasm	0.000182	0.000781	CbGpPWpGaD
Suramin—F2—Hemostasis—HGF—peripheral nervous system neoplasm	0.00018	0.000772	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GNS—peripheral nervous system neoplasm	0.000179	0.000765	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000177	0.000757	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000173	0.000741	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NME1—peripheral nervous system neoplasm	0.000171	0.000733	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HGF—peripheral nervous system neoplasm	0.000165	0.000706	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—COX2—peripheral nervous system neoplasm	0.000165	0.000706	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000163	0.000699	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	0.000162	0.000693	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000159	0.00068	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000157	0.000671	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000157	0.00067	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000156	0.000668	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000153	0.000657	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000151	0.000645	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000149	0.000639	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GNAS—peripheral nervous system neoplasm	0.000149	0.000638	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000147	0.000629	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000146	0.000626	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000143	0.000613	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000137	0.000586	CbGpPWpGaD
Suramin—F2—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000131	0.000563	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000124	0.000532	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000124	0.00053	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000123	0.000528	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000121	0.000516	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00012	0.000515	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00012	0.000512	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000119	0.00051	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000116	0.000497	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000115	0.000491	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000114	0.000489	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000114	0.000486	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000113	0.000485	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000113	0.000484	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000112	0.00048	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000112	0.000479	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000109	0.000467	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000109	0.000465	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—peripheral nervous system neoplasm	0.000108	0.000463	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000108	0.000463	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000104	0.000447	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—peripheral nervous system neoplasm	0.000104	0.000444	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000103	0.000439	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000102	0.000436	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.93e-05	0.000425	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.91e-05	0.000424	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.91e-05	0.000424	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.38e-05	0.000402	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—BCHE—peripheral nervous system neoplasm	9.14e-05	0.000391	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.06e-05	0.000388	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.06e-05	0.000388	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.74e-05	0.000374	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.72e-05	0.000373	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TH—peripheral nervous system neoplasm	8.59e-05	0.000368	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.58e-05	0.000367	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.44e-05	0.000361	CbGpPWpGaD
Suramin—F2—Hemostasis—NRAS—peripheral nervous system neoplasm	7.91e-05	0.000339	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.84e-05	0.000336	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.55e-05	0.000323	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.34e-05	0.000314	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NRAS—peripheral nervous system neoplasm	7.23e-05	0.00031	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—AKT1—peripheral nervous system neoplasm	7.19e-05	0.000308	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.17e-05	0.000307	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GNAS—peripheral nervous system neoplasm	7.02e-05	0.0003	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.99e-05	0.000299	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.93e-05	0.000297	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.9e-05	0.000296	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCB1—peripheral nervous system neoplasm	6.88e-05	0.000295	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.86e-05	0.000294	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.71e-05	0.000287	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.63e-05	0.000284	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.41e-05	0.000275	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.39e-05	0.000274	CbGpPWpGaD
Suramin—ARSA—Metabolism—AKT1—peripheral nervous system neoplasm	6.24e-05	0.000267	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.06e-05	0.000259	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—peripheral nervous system neoplasm	6.05e-05	0.000259	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.87e-05	0.000251	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.85e-05	0.000251	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—peripheral nervous system neoplasm	5.78e-05	0.000248	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—peripheral nervous system neoplasm	5.53e-05	0.000237	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—peripheral nervous system neoplasm	5.29e-05	0.000227	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT1—peripheral nervous system neoplasm	5.11e-05	0.000219	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT1—peripheral nervous system neoplasm	4.67e-05	0.0002	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.54e-05	0.000194	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.46e-05	0.000191	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.15e-05	0.000178	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.08e-05	0.000175	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.02e-05	0.000172	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.52e-05	0.000151	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.32e-05	0.000142	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.23e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.22e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.2e-05	0.000137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.04e-05	0.00013	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.93e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.92e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.68e-05	0.000115	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.68e-05	0.000115	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.5e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.45e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.28e-05	9.78e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.05e-05	8.78e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.96e-05	8.4e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-05	8.11e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.88e-05	8.03e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.79e-05	7.68e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.73e-05	7.41e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.58e-05	6.78e-05	CbGpPWpGaD
